Episode 24: The CRISPR Revolution: Exploring Gene Editing and Careers in Business Development with Dr. Alex Harding, Senior Vice President and Head of Business Development at CRISPR Therapeutics

Episode 24: The CRISPR Revolution: Exploring Gene Editing and Careers in Business Development with Dr. Alex Harding, Senior Vice President and Head of Business Development at CRISPR Therapeutics

Healthscape takes a fascinating turn as Pam Divack chats with Dr. Alex Harding, the Senior Vice President and Head of Business Development at CRISPR Therapeutics. Ever wondered how someone goes from a history major to a biotech leader? Dr. Harding shares his unconventional journey, offering a glimpse into the twists and turns that led him to spearhead business development in one of the most exciting fields of gene editing.

CRISPR technology is making waves, and Harding explains why it’s considered revolutionary, shedding light on its applications in human therapeutics. The conversation isn't just about science; it's a deep dive into the world of biotech business development. Harding offers practical advice for those looking to carve a niche in this dynamic field, emphasising the importance of marrying business acumen with scientific understanding.

He paints a vivid picture of his role at CRISPR Therapeutics, where deal-making and strategic planning are part of the daily grind. CRISPR's broad applicability means that partnerships are key, and Harding discusses how these collaborations can unlock new potentials in gene editing. Whether you're an aspiring healthcare leader or just curious about the future of medicine, this episode provides a unique perspective on how cutting-edge technology is reshaping the industry. So, what does the future hold for CRISPR?

Harding’s insights might just spark your curiosity about where gene editing is headed next. Are you ready to explore how this technology could revolutionise healthcare and improve lives?